Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A

UPDATED on 2/28/2024

On 1/28/2024 Arav Gandhi DROP OUT of LPBI Group’s One-Year Internship Program

https://pharmaceuticalintelligence.com/certificate-1-year/

He has used my Letter of Recommendation (LOR) to CommonApp.org which was intended for Early Admission ONLY for his Regular Admission without asking for my permission and sharing which colleges my LOR was used for
After using my LOR for both Early Admission and Regular Admission which was written referring to future work to be completed and we had agreed upon that LORs are written ONLY for work completion,
Student had VOLUNTARILY DROPPED OUT OF THE INTERNSHIP PROGRAM which created a situation that the LOR was obtained in violation of our Guidelines
This matter is been currently addressed by me with CommonApp.org

The Scope of the project was scaled back and not even ONE volume was brought to completion.

His name was removed from Volume Seven, the 2nd Edition of Volume One
Work that was completed will be acknowledged
A bridge was burnt by a 12th grade student with his Academic Mentor for the Internship at LPBI Group
I question student’s moral clarity, ability to maintain commitments and ethical behavior expected from College students, chiefly, these planning careers in Health Care
Student did not reply to any e-mail message after 1/28/2024

From: Arav Gandhi <aravg2323@gmail.com>
Date: Sunday, January 28, 2024 at 9:54 AM
To: Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu>
Subject: Re: How are you?

Good Morning,

I have not made much progress since we last spoke, but I plan to finish Volume One by the end of next week. Sorry for the delay, and I hope you understand. Thank you ina advance for your response.

From,

Arav Gandhi
SHS IB Senior

On Sat, Jan 27, 2024 at 5:19 PM Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu> wrote:

Please share the progress on Volume One.

@@@

Internship Scope was scaled back per the following TWO e-mail:

No response and
No show up to Zoom on 2/25/2024

From: Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu>
Date: Saturday, February 17, 2024 at 5:38 PM
To: Arav Gandhi <aravg2323@gmail.com>
Subject: Volume Seven: 2nd Edition of Volume One: Title of Volume Seven: Text Mining with Machine Learning, Book Glossary from Article’s WordClouds. Title of Volume One: Perspectives on Nitric Oxide in Disease Mechanisms | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/series-a-volume-7-cardiovascular-content-text-mining-analysis-using-machine-learning-master-glossary-across-six-volumes-built-from-articles-wordclouds/

Dear ARAV,

Please bring to completion Volume 7 which is 2^nd Edition of Volume 1 by 3/31/2024

I am sending you now Volume 8 which is 2^nd Edition of Volume 2 by 6/30/2024

I will Publish these two books in 2024.

I do not think that we will continue beyound that with NEW books for Series A.

We published:

18 volumes in English Edition + 5 series = 23

We published:

19 Volumes in Spanish Edition +5 Series = 24

Together = 47

We published Audio Podcast Library – 1 Volume
We will publish Volume 7 and Volume 8 in Series A as 2^nd Edition for Volume 1 & 2

Together = 50 VOLUMES – This is my Legacy as Editor-in-Chief.

Upon completion of Volume 8

You will be welcome to work with me on Updating all the articles in https://pharmaceuticalintelligence.com/biomed-audio-podcast-library-lpbi-group/

Chapter 18: Cardiovascular – 36 Audio Podcasts.

In the Journal 1,107 articles in Frontiers in Cardiology and in Cardiovascular Research, just two of the +20 categories on heart diseases

11, 13, 18, 25, 45, 46, 57, 62, 65, 66, 67, 68, 69, 70,

73, 74, 82, 86, 87, 88, 92, 94, 105, 106, 107, 111,

118, 135, 141, 173, 174, 235, 252, 258, 262, 300

Please send me comments

THANK YOU

Best regards,

Aviva

Aviva Lev-Ari, PhD, RN

Director & Founder

https://lnkd.in/eEyn69r

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston, MA

Editor-in-Chief

http://pharmaceuticalintelligence.com

e-Mail: avivalev-ari@alum.berkeley.edu

(M) 617-775-0451

https://cal.berkeley.edu/AvivaLev-Ari,PhD,RN

LinkedIn Profile Twitter Profile

From: Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu>
Date: Saturday, February 17, 2024 at 6:35 PM
To: Arav Gandhi <aravg2323@gmail.com>
Cc: “Dr. Stephen J. Williams” <sjwilliamspa@comcast.net>, “Stephen Williams, PhD” <stephenwilliamspharmintell@gmail.com>
Subject: Volume Eight: 2nd Edition of Volume Two: Title of Volume Eight: Text Mining with Machine Learning, Book Glossary from Article’s WordClouds. Title of Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-eight-2nd-edition-of-volume-two-title-of-volume-eight-text-mining-with-machine-learning-book-glossary-from-articles-wordclouds-title-of-volume-two-cardiovascular-original-researc/

THIS IS VOLUME EIGHT in Series A: Cardiovascular Diseases

Please complete by 6/30/2024

THIS IS THE ORIGINAL VOLUME TWO so you do not need to carry over the Editorials – THERE are in their original place.

Start in the body of the book to convert to Sound each article AFTER you had identified all the articles in Volume Seven which is NOW 2^nd Edition of Volume 1.
No need to repeat
AFTER all articles in this book are in AUDIO
Start to

create Word Clouds for each article
upload to Gallery the WordCloud
Create LEGEND for each word Cloud – Article ID, Title, date of Publication, Your name as Produced of the Image
Upload the Image to the original article
Upload the Image to the BODY of the book per each article inside each Chapter
COMPLETE all book
AT THE END OF THE BOOK you will ADD (A) Glossary (B) selection of 5 WordClouds per Chapter

GOOD LUCK

Keep me posted evety TWO WEEKS with Progress report.

THANK YOU

Best regards,

Aviva

Aviva Lev-Ari, PhD, RN

Director & Founder

https://lnkd.in/eEyn69r

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston, MA

Editor-in-Chief

http://pharmaceuticalintelligence.com

e-Mail: avivalev-ari@alum.berkeley.edu

(M) 617-775-0451

https://cal.berkeley.edu/AvivaLev-Ari,PhD,RN

LinkedIn Profile Twitter Profile

@@@@@@@@@@@@@@@@@@@@@@

Roles @LPBI Group

Academic Mentor:

Aviva Lev-Ari, PhD, RN

In 2013 to 2018, we published

Series A: Cardiovascular Diseases ($515)

https://www.amazon.com/gp/product/B07P981RCS?ref_=dbs_p_mng_rwt_ser_shvlr&storeType=ebooks

Series A, Volume One

Perspectives on Nitric Oxide in Disease Mechanisms, 2013